Bayer AG has its eyes set on the Latin American country Brazil to win back profits lost from lawsuits and bad press surrounding its blockbuster birth control pill Yaz. The German pharmaceutical company announced this week that it expects to post double-digit annual growth in Brazil through the next four years, from 15 billion in 2008 to a whopping $27 billion by 2015. Chairman Andreas Fibig told reporters at a press conference in Sao Paulo that the company’s strong market position in Brazil, paired with new products that will be introduced to the Latin American market in the months and ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.